Nabumetone
- Product NDC
- 70518-3835
- 11-digit product format
- 705183835
- Labeler code
- 70518
- Product ID
- 70518-3835_3f68d0c6-26a6-df70-e063-6294a90a1f75
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Nabumetone
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- REMEDYREPACK INC.
- Application
- ANDA078420
- Marketing category
- ANDA
- Marketing start
- 2023-08-18
- Substance
- NABUMETONE
- Active strength
- 500 mg/1
- Pharmacologic classes
- Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| LW0TIW155Z | NABUMETONE | 42924-53-8 | NABUMETONE |
Packages
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 70518-3835-0 | 70518383500 | 14 TABLET in 1 BOTTLE, PLASTIC (70518-3835-0) | 14 tablet | 2023-08-18 | No | No | Historical |
| 70518-3835-1 | 70518383501 | 60 TABLET in 1 BOTTLE, PLASTIC (70518-3835-1) | 60 tablet | 2024-03-12 | No | No | Historical |